Literature DB >> 28797493

Allergic and Noninvasive Infectious Pulmonary Aspergillosis Syndromes.

Eavan G Muldoon1, Mary E Strek2, Karen C Patterson3.   

Abstract

Aspergillus spp are ubiquitous in the environment, and inhalation of Aspergillus spores is unavoidable. An intact immune system, with normal airway function, protects most people from disease. Globally, however, the toll from aspergillosis is high. The literature has largely focused on invasive aspergillosis, yet the burden in terms of chronicity and prevalence is higher for noninvasive Aspergillus conditions. This article discusses allergic aspergilloses and provides an update on the diagnosis and management of allergic bronchopulmonary aspergillosis, including in patients with cystic fibrosis, and an update on severe asthma with fungal sensitization. In addition, the presentation, investigation, and management of noninvasive infectious aspergilloses are reviewed.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ABPA; Aspergillus; Aspergillus bronchitis; Chronic fungal infection of lung

Mesh:

Year:  2017        PMID: 28797493     DOI: 10.1016/j.ccm.2017.04.012

Source DB:  PubMed          Journal:  Clin Chest Med        ISSN: 0272-5231            Impact factor:   2.878


  11 in total

1.  Allergic bronchopulmonary aspergillosis presumably unmasked by PD-1 inhibition.

Authors:  Anthony A Donato; Ronald Krol
Journal:  BMJ Case Rep       Date:  2019-02-13

2.  Daily dose of itraconazole 100 mg to treat allergic bronchopulmonary aspergillosis (ABPA) related eosinophilia: a case report.

Authors:  A E Konstantinou; E Christaki; C Pitsios
Journal:  Hippokratia       Date:  2017 Jul-Sep       Impact factor: 0.471

3.  Interactions of Extracellular Vesicles from Pathogenic Fungi with Innate Leukocytes.

Authors:  Mateus Silveira Freitas; Andre Moreira Pessoni; Carolina Coelho; Vânia Luiza Deperon Bonato; Marcio L Rodrigues; Arturo Casadevall; Fausto Almeida
Journal:  Curr Top Microbiol Immunol       Date:  2021       Impact factor: 4.291

Review 4.  Cutaneous Manifestations of Infections in Solid Organ Transplant Recipients.

Authors:  Cory J Pettit; Katherine Mazurek; Benjamin Kaffenberger
Journal:  Curr Infect Dis Rep       Date:  2018-05-22       Impact factor: 3.663

5.  Recurrence of allergic bronchopulmonary aspergillosis after adjunctive surgery for aspergilloma: a case report with long-term follow-up.

Authors:  Kohei Horiuchi; Takanori Asakura; Naoki Hasegawa; Fumitake Saito
Journal:  BMC Pulm Med       Date:  2018-12-04       Impact factor: 3.317

6.  Hospital Environment as a Source of Azole-Resistant Aspergillus fumigatus Strains with TR34/L98H and G448S Cyp51A Mutations.

Authors:  Irene Gonzalez-Jimenez; Jose Lucio; Maria Dolores Menéndez-Fraga; Emilia Mellado; Teresa Peláez
Journal:  J Fungi (Basel)       Date:  2021-01-02

7.  Epidemiology of fungal diseases in Africa: A review of diagnostic drivers.

Authors:  Felix Bongomin; Samuel Adetona Fayemiwo
Journal:  Curr Med Mycol       Date:  2021-03

8.  Multiresistance to Nonazole Fungicides in Aspergillus fumigatus TR34/L98H Azole-Resistant Isolates.

Authors:  I Gonzalez-Jimenez; R Garcia-Rubio; S Monzon; J Lucio; I Cuesta; E Mellado
Journal:  Antimicrob Agents Chemother       Date:  2021-08-17       Impact factor: 5.191

9.  Evaluation of the Antifungal Activity of the Novel Oral Glucan Synthase Inhibitor SCY-078, Singly and in Combination, for the Treatment of Invasive Aspergillosis.

Authors:  M Ghannoum; L Long; E L Larkin; N Isham; R Sherif; K Borroto-Esoda; S Barat; D Angulo
Journal:  Antimicrob Agents Chemother       Date:  2018-05-25       Impact factor: 5.191

10.  The IL-1 Receptor Is Required to Maintain Neutrophil Viability and Function During Aspergillus fumigatus Airway Infection.

Authors:  Benjamin Awr Ralph; Melanie Lehoux; Hanna Ostapska; Brendan D Snarr; Alayna K Caffrey-Carr; Richard Fraser; Maya Saleh; Joshua J Obar; Salman T Qureshi; Donald C Sheppard
Journal:  Front Immunol       Date:  2021-07-12       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.